Recombinant IL13 (Lebrikizumab Biosimilar) 抗体
This anti-IL13 (Lebrikizumab Biosimilar) antibody is a Human 单克隆 antibody detecting IL13 (Lebrikizumab Biosimilar) in ELISA, BLI, FACS, Func 和 SPR. Suitable for 人.
产品编号 ABIN7676016
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Recombinant IL13 (Lebrikizumab Biosimilar) 抗体 (ABIN7676016)
抗原
IL13 (Lebrikizumab Biosimilar)
抗体类型
Recombinant Antibody
适用
人
宿主
Human
克隆类型
单克隆
标记
This IL13 (Lebrikizumab Biosimilar) antibody is un-conjugated
应用范围
ELISA, Bio-Layer Interferometry (BLI), Flow Cytometry (FACS), Functional Studies (Func), Surface Plasmon Resonance (SPR)
-
-
Expression System
- CHO Cells
-
原理
- Anti-IL-13 Reference Antibody (lebrikizumab)
-
产品特性
- Anti-IL-13 Reference Antibody (lebrikizumab) is expressed from CHO. The heavy chain type is huIgG4SP, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
-
纯度
- >95 %
-
亚型
- IgG4 S228P
-
-
-
-
应用备注
- Optimal working dilution should be determined by the investigator.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
浓度
- 1 mg/mL
-
缓冲液
- 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
-
储存条件
- 4 °C,-80 °C
-
储存方法
- +4°C,-80°C
-
-
- IL13 (Lebrikizumab Biosimilar)
-
别名
- IL-13 (Lebrikizumab Biosimilar)
-
物质类
- Biosimilar
-
分子量
- 145.5 kDa
-
UniProt
- P35225
抗原
-
You are here:
